Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Ruxolitinib cream may help treat severe hair loss in children.

Jujube fruit may help prevent anemia by boosting blood production.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Upadacitinib effectively treats psoriasis and lichen planus together.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Jujube seeds have many health benefits and could be a valuable natural remedy.

An arthritis drug helped a person with severe hair loss regrow their hair.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

A patient with complete hair loss regrew all her hair using tofacitinib.

These new skin treatments are safer and more effective with minimal side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.